First Trust Advisors LP Organogenesis Holdings Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.74 - $8.15 $518,499 - $891,512	-109,388 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.47 - $9.57 $508,089 - $751,532	-78,530 Reduced 41.79%	109,388 $834,000
Q4 2021 Feb 08, 2022	SELL	$9.02 - $13.5 $745,737 - $1.12 Million	-82,676 Reduced 30.55%	187,918 $1.74 Million
Q3 2021 Nov 15, 2021	SELL	$13.71 - $17.18 $757,779 - $949,572	-55,272 Reduced 16.96%	270,594 $3.85 Million
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $4.86 Million - $7.57 Million	325,866 New	325,866 $5.42 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.